China Nuokang Bio-Pharmaceutical Q2 Profit Down - Quick Facts

8/22/2012 6:36 PM ET

China Nuokang Bio-Pharmaceutical Inc. (NKBP: Quote) reported that its second-quarter net income was RMB10.5 million or $1.7 million, down from RMB14.1 million in the prior year period. Net income was RMB0.56 or $0.09 per ADS, compared to RMB0.72 per ADS last year.

Non-GAAP adjusted net income, excluding foreign exchange gains and losses, ESOP-related charges and the ASC 740 adjustment, were RMB11.3 million or $1.8 million, compared to RMB15.7 million in the prior year period.

Revenue for the second quarter of 2012 was RMB72.9 million or $11.5 million, compared to RMB79.5 million in the second quarter of 2011.

Click here to receive FREE breaking news email alerts for China Nuokang Bio-Pharmaceutical Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

<<Previous 138 Articles

Editors Pick

Red Hat Results Edge Past Estimates

Red Hat Inc., the world's largest seller of Linux software, said Wednesday after the markets closed that its first quarter profit rose 8% from last year, as revenue increased 15% amid strong consumer demand. The company's quarterly earnings per share, excluding items, also came in above analysts' expectations as did its quarterly revenue.

Negative Reaction To Fed Leads To Sell-Off On Wall Street - U.S. Commentary

After moving mostly higher over the course of the two previous sessions, stocks pulled back sharply during trading on Wednesday. A negative reaction to the Federal Reserve's monetary policy announcement weighed on the markets in afternoon trading. The major averages saw some volatility following the announcement from the Fed, closing firmly in the red.

CBO Finds Senate Immigration Bill Would Reduce Budget Deficit

Providing a potential boost to comprehensive immigration reform, the non-partisan Congressional Budget Office has estimated that the immigration bill currently being debated in the Senate would result in a notable reduction to the federal budget deficit.